EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 29.11 ($0.38) and traded as low as GBX 27.26 ($0.35). EKF Diagnostics shares last traded at GBX 27.75 ($0.36), with a volume of 282,148 shares trading hands.
EKF Diagnostics Stock Performance
The firm has a market capitalization of £124.78 million, a price-to-earnings ratio of 2,775.00 and a beta of 0.57. The company has a 50-day moving average price of GBX 28.76 and a 200-day moving average price of GBX 29.11. The company has a quick ratio of 1.77, a current ratio of 4.59 and a debt-to-equity ratio of 1.78.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Read More
- Five stocks we like better than EKF Diagnostics
- Dividend Capture Strategy: What You Need to Know
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What are earnings reports?
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
